Read Part 1 first if you have not. It diagnoses the operational stack a PE-backed DSO installs at an implant practice and argues the operational model is separable from the equity transfer. This post ships the install-it-yourself version.
Part 1 argued the operational model is the asset and the equity transfer is the packaging. Part 2 ships the answer. The 2026 operational stack for an independent implant practice ships in 30 days from contract, is owned by the practice, runs around $5,000 per month in total software cost, and replaces roughly $10,000 to $15,000 of monthly payroll in headcount the practice no longer needs to hire. The system fits how the practice already operates.
This post is for the implant practice owner who read Part 1, recognized the PE operational playbook, and wants the install-it-yourself version. It is also for the owner who is being approached by a PE-backed DSO right now and wants to know whether the operational benefits the DSO promises are actually obtainable independently. The answer is yes, and below is the specific stack Choice OMG installs, the 30-day plan we run, what it costs, and the trajectory across the implant practices already on the stack. The post names the trade-offs honestly. There are practices where the DSO partnership is the right answer, and the closing section names them.
Build beats buy at single-practice scale
A Salesforce-class CRM was the right answer for a 750-office DSO and the wrong answer for one location. Platform-scale economics and practice-scale economics are not the same problem. The Frontline DIS Salesforce instance described in Part 1 was the right answer at 14+ practice scale. At one practice it is overbuilt, overpriced, and slow to install.
The AI-augmented custom-build alternative is tailored to the practice's specific patient journey, owned outright, and ships inside the 30-day install window. Build-versus-buy economics inverted around 2024 because the tooling changed. Coding agents like Claude Code, Cursor, and GitHub Copilot now ship working software from prose specifications, in hours where a contracted engineering team would have billed weeks. A custom call-tracking-to-CRM attribution layer for one practice that would have been a multi-week consultant engagement in 2022 is now a two-day build with one operator and a coding agent. A consulting firm arrives with a pre-built system and a training program: the practice learns to work the way the system requires. The AI-build approach inverts that. The system gets built to match how the practice operates. Change management is the largest hidden cost in most operational technology engagements, and this approach reduces it materially because the system fits existing workflows rather than imposing new ones; some staff retraining is still required, just dramatically less than a SaaS rollout.
Examples of what Choice OMG builds in days that a SaaS configuration would take weeks: custom attribution dashboards, intake-to-case-tracking pipelines, MROI reporting layers, AIO-citation content systems, AI-personalized post-consult email and SMS sequences referencing each patient's specific procedure plan. Plus AI-augmented operational automation that would normally require dedicated staff: text alerts to the office manager when something needs attention, personalized appointment reminders that draw on each patient's procedure history, automated follow-up sequences for unbooked consults. These are small, real, and effectively free to run at AI prices.
The PE stack worked for what it was designed for. The 2026 stack should be built differently because the build-tooling has changed. This is an upgrade in approach, not a rejection of the model.
The 2026 stack for an independent implant practice, component by component
The stack has seven components. Each one is named, each one is owned by the practice, and each one is built or integrated in the 30-day install plan described later.
| Component | What it does | How Choice OMG builds it |
|---|---|---|
| Discovery layer | Surfaces the practice in AI answers, traditional SERPs, and local results | Schema markup, FAQ-structured content, expert credentialing, third-party citations, GBP optimization |
| Attribution and call tracking | Credits every consultation to the right campaign across the multi-week implant decision window | Custom AI-augmented attribution sized for one practice; CallRail-level call tracking; custom Twilio infrastructure where it adds value |
| CRM and lead-to-case pipeline | Tracks the consultation, financing, treatment-plan, and case-completion stages | Custom-built, owned by the practice, not a Salesforce subscription |
| Treatment-coordinator role design | Structures the financing conversation around clinical-quality outcomes | Role design and script aligned with clinical accountability, not production quotas |
| Financing menu | Surfaces CareCredit, in-house plans, and Proceed Finance as menu options | Integrated into the consultation flow, presented as options the patient and dentist work through together |
| Case-acceptance nurture (multi-channel) | Converts attended consults into accepted cases | AI-personalized email and SMS sequences, video remarketing on Meta and YouTube, branded TV and radio strategy |
| Relationship layer | Drives recall, referral, and retention | Patient communication automation, review-cycle prompts, structured referral programs |
Three components warrant detail.
Discovery layer. Implant patients now research on AI Overviews, ChatGPT, Perplexity, and YouTube as much as on Google's traditional results. The discovery layer is the work of getting cited in those answers and ranking in those results. Schema markup, FAQ-structured content, expert credentialing, and third-party citations are the long-cycle compounding investments. Local-pack optimization and traditional Google Search are the shorter-cycle ones. Both matter.
Attribution and call tracking. Implant cases close on weeks, not minutes. A first-touch model misattributes the eventual case to the wrong campaign; a last-touch model misattributes it to whatever was running on the day the patient called. The multi-touch model gets built custom to the practice. It credits the channels that actually drove the qualified full-arch consult, not just the channel that filled the top of the funnel.
Case-acceptance nurture (multi-channel). This is what converts an attended consultation into an accepted case. The sequence: AI-personalized email referencing the patient's specific procedure plan and financing options, SMS follow-up timed to the patient's stated decision window, and video remarketing on Meta and YouTube that surfaces the dentist's clinical credibility and patient-outcome stories to the warm audience. Compliance posture: any workflow that touches protected health information runs on BAA-covered AI vendors and infrastructure; non-PHI content (general appointment reminders, broadcast creative, public-facing pages) runs on the broader AI stack. For practices with a meaningful full-arch case mix, add a branded TV and radio layer to build top-of-funnel awareness so the practice name is already familiar at consult time. Broadcast carries the highest CPM in the stack and is only justified where individual case values ($25K to $45K for full-arch) cover the cost of presence; for practices that are hygiene-and-single-implant heavy, skip the broadcast layer and reinvest in the relationship layer. Media spend for paid and broadcast channels is paid by the practice directly and is on top of the software cost; Choice OMG designs and manages the strategy.
Why this works at single-practice scale
Heartland-supported offices spend 2.9% of revenue on supplies versus an 8.7% industry average. That is the order of magnitude of the operational compounding the PE stack delivered at platform scale. The AI-build approach delivers comparable operational efficiency for one practice without the SaaS subscription tax. The cost-side compounding does not require a 750-office network anymore. It requires the right system, built the right way, for the way the practice actually operates.
What this costs
The total monthly software cost for the 2026 stack is targeted at around $5,000. That covers the custom-built attribution and CRM layers, the call tracking and reporting infrastructure, the AI-augmented automation, and ongoing campaign management across paid and organic channels.
The $5,000 figure is the introductory launch price for the AI-built stack offer described in this post; steady-state pricing as scope and case mix grow may shift up. It is not the average of current legacy retainers across Choice OMG's existing client mix.
The comparison that matters is against the traditional alternative. A consulting firm engagement that installs SaaS and trains staff to work differently around it, plus the headcount required to operate that stack at single-practice scale, lands very differently. A typical CRM-plus-integration-plus-reporting stack at single-practice scale requires roughly three full-time staff to manage. At single-practice payroll rates, three FTEs is $10,000 to $15,000 per month before benefits. The Choice OMG approach replaces that payroll with $5,000 in software, a net swing of $5,000 to $10,000 per month going back to the practice's bottom line. The system gets built to fit how the practice already works, and the operational small-stuff runs on AI that costs effectively nothing.
| Line item | Included in the $5,000 |
|---|---|
| Custom-built attribution layer | Yes |
| Custom CRM equivalent and lead-to-case pipeline | Yes |
| Call tracking infrastructure (CallRail-class plus custom Twilio) | Yes |
| AI-augmented operational automation | Yes |
| Reporting dashboards and MROI layer | Yes |
| Paid and organic campaign management | Yes |
| Discovery-layer content production | Yes |
| Media spend for paid search, paid social, programmatic, TV, radio | No (paid by the practice directly) |
| New headcount at the practice | No (the system replaces the headcount need, not adds to it) |
The 30-day install plan
Thirty days from contract to fully operational stack. The first two weeks are the build phase, where the AI-build-versus-SaaS-buy advantage matters most. The remaining two weeks are operational integration, campaign restructuring, and the relationship layer. Day 31 the stack is live and producing.
| Days | Milestone | What ships |
|---|---|---|
| 1 to 7 | Discovery and build kickoff | Discovery-layer assessment, AIO/SERP audit, custom CRM build, intake-to-case schema designed |
| 8 to 14 | Attribution, reporting, automation | Custom attribution layer wired across Google Ads, Meta, GA4, GBP, and call tracking; CallRail and custom Twilio deployed; MROI dashboards live; office-manager text alerts, personalized appointment reminders, and AI follow-up sequences for unbooked consults turned on |
| 15 to 21 | Campaigns, coordinator, financing | Paid search, paid social, and YouTube remarketing campaigns rebuilt; treatment-coordinator training delivered where applicable; financing menu integrated into the consultation flow |
| 22 to 30 | Scheduling, relationship, content | Production scheduling logic adjusted to clinical pace; recall sequences, referral programs, and post-case review prompts deployed; first content batch shipped for discovery-layer compounding |
| 31 | Operational | Full stack live and producing; weekly reporting cadence in place |
What the trajectory actually looks like (with the data caveats)
The data below is from across the implant practices Choice OMG has integrated into its reporting stack (N=2). This is the subset our reporting infrastructure has data for, not industry-wide and not Choice OMG's full implant book. The methodology-disclosure move is a feature, not a weakness. Two practices, two stories, one recent-quarter cost snapshot.
Client A: 17 months on the stack
Engagement window: January 2025 to May 2026. Full reporting stack integrated since the start. The story this practice tells is about discovery-layer compounding.
- Organic search position improved from rank 35 to rank 13 across the 17-month window.
- Monthly organic impressions grew from ~53,000 to ~84,000, with peak months above 150,000.
- Clicks held flat in absolute terms; the position-improvement and impressions-growth story is the strong one. The article is not overclaiming on clicks.
Client B: newer engagement, channel-mix in motion
Engagement window starts later than Client A. Full reporting stack integrated more recently. The story this practice tells is about the rebalance from paid to organic.
- Paid-channel share of GA4 sessions dropped from a peak of 84% (April 2025) to a 30% to 47% range in spring 2026.
- Organic share rose from 5% to 38% over the same window.
- This is the cleanest AI-discovery and organic-emphasis trajectory in the data.
Recent-quarter cost economics across the subset (March to May 2026)
| Metric | Value |
|---|---|
| Blended marketing CPL (total paid spend รท all-source leads) | $60 to $94 per lead |
| Google Ads CPA, steady-spend account | $28 to $58 |
| Google Ads CPA, aggressive-scale-up account | $236 to $477 |
| Monthly paid-ad spend range | $1,500 to $15,000 Google Ads; $100 to $1,600 Meta where present |
The spread between the two CPAs is the story, not the average. The aggressive-scale-up CPA reflects a practice intentionally running paid acquisition above its long-term steady-state CPL to capture top-of-funnel volume; that is not the sustainable per-lead cost.
Caveats: daily Google Ads spend data in our reporting infrastructure only goes back to mid-March 2026, so the spend-side trend across the full engagement is not available. The organic-search trajectory and the channel-mix evolution are the long-horizon trajectories the data supports; the cost snapshot is the recent-quarter view. Per-patient revenue, case-acceptance rates, and full-arch case volume live in the practice management software and are out of scope for this analysis.
When the alternative does not work
Four practice types where the DSO partnership is genuinely the right answer:
- Succession-driven exits. An owner ready to phase out clinical practice and monetize the equity now has a different problem than the independent stack solves. The DSO transaction structures the exit; the rollover equity captures some of the post-close upside.
- Founder burnout. The independent stack requires the owner to remain operationally engaged. The DSO answer removes that requirement at the cost of the equity. For an owner who wants to step back, that trade is rational.
- Geographically isolated practices that cannot scale. A small market with saturated local demand has limited operational growth available. The DSO provides centralized marketing, centralized purchasing, and a regional referral network the independent stack cannot replicate at that scale.
- Owners who want no operational involvement. Some clinicians want to practice clinically and have someone else run the business. The DSO answer fits that preference. The independent stack does not.
The thesis is not "PE is always wrong." It is that the operational benefits the DSO promises are independently obtainable for the practice owner who wants to stay operationally engaged. If you do not want to stay operationally engaged, the calculation is different.
The thesis
The operational model is the asset. The AI-built 2026 version is faster to install, cheaper to operate, and owned by the practice. The independent practice that installs this stack this month is positioning for this cycle, not just this quarter.
The PE-era playbook assumed multi-week SaaS configurations were the only path to operational sophistication. That assumption is no longer true. The build-tooling changed. The stack a PE-backed DSO needed Salesforce and a regional operations team to deliver is now buildable for one practice in a fraction of the time and cost. The opportunity is to install it without the equity transfer.
FAQ
Q: How long does it take Choice OMG to install the full 2026 stack at an independent implant practice? A: Thirty days from contract to fully installed. The build phase (custom AI-augmented attribution layer and the practice-tailored CRM equivalent) takes the first two weeks because that is where the AI-build-versus-SaaS-buy advantage matters most. The remaining two weeks cover campaign restructuring, treatment-coordinator training where applicable, financing menu integration, production scheduling adjustments, and the relationship-layer setup. Day 31 the stack is operational.
Q: How much does Choice OMG charge to install and run this stack? A: Forward-looking target price for the AI-built stack offer is around $5,000 per month in total software cost. That covers the custom-built attribution layer, the custom CRM equivalent, the call tracking and reporting infrastructure, the AI-augmented automation, and ongoing campaign management across paid and organic channels. Media spend for paid channels and the broadcast layer is on top, paid by the practice directly. Compare against the traditional alternative: a consulting engagement that installs SaaS plus the roughly three full-time staff a practice would typically need to operate a CRM-plus-integration-plus-reporting stack at single-practice scale.
Q: What is the actual difference between Choice OMG's AI-built attribution and a Salesforce setup? A: A Salesforce instance for a single dental practice is a multi-week configuration project that produces a system more powerful than the practice needs and more expensive than the practice should pay. Choice OMG builds the equivalent in days using AI-augmented custom development. The result is tailored to the practice's specific patient journey, owned outright by the practice, and significantly cheaper to operate over the lifecycle. The Frontline DIS Salesforce instance described in Part 1 was the right answer at 14+ practice scale; it is the wrong answer at one-practice scale.
Q: What if my practice is already on a SaaS contract I cannot exit? A: Choice OMG works on top of existing software. The custom-built layer is the attribution and reporting glue that ties existing tools together and adds the AI-augmented decision support none of them deliver standalone. The SaaS contracts you have already paid for keep running. The Choice OMG build replaces the configuration overhead, not the underlying tools.
Q: How does this compare to just hiring a marketing-only agency? A: Most marketing-only agencies stop at the campaign management layer. The 2026 stack Choice OMG installs covers the discovery layer, the attribution layer, the CRM and lead-to-case pipeline, the financing and treatment-coordinator design, the case-acceptance nurture, and the relationship layer. A marketing-only agency runs ads. Choice OMG runs the operational stack the ads feed into.
Q: Do I keep ownership of the system Choice OMG builds? A: Yes. The custom-built attribution layer, the CRM equivalent, the reporting dashboards, and the integration glue are built for the practice and owned by the practice. If the engagement with Choice OMG ends, the practice keeps everything: the data, the system, the integrations. No SaaS lock-in is the point of the build-with-AI approach.
Author note
I built the call tracking, conversion attribution, and marketing ROI reporting at the Texas implant practice described in Part 1. I watched the rest of the PE operational stack get installed around me. I did not build the Salesforce side; I built the front-of-funnel tracking layer that fed it. I am the named author of this post, and the alternative it recommends is the agency I run.
I now run Choice OMG, a Canadian-based dental and healthcare marketing agency founded in 2010 that builds the acquisition-tracking and operational stack for independent dental practices. If the audience for this post acts on the recommendation, my business benefits. That is a direct conflict of interest, disclosed in the lede, the FAQ, and here. I was paid as a marketing analytics contractor by the Texas practice during the integration window described above; I have not taken any payment, sponsorship, or commercial consideration from any entity involved in this story since. The conflict cuts the other direction too: I could build the same agency relationship with PE-backed DSOs and have access to a much larger market. The deliberate choice to focus on independent practices comes from a view that the value transfer in PE acquisitions is increasingly one-sided against the selling dentist.
The thesis stands despite the conflict because the conflict is structurally consistent with the reader's interest. The reader who installs the independent stack keeps the equity, keeps the operational decision-making, and gets the operational compounding the PE playbook promised. Where the data does not support a specific claim, I have flagged it. The N=2 disclosure in the trajectory section is the example: the data is real, but the sample is the subset Choice OMG has integrated into its reporting infrastructure, not the universe of implant practices. The research backs the broader thesis (Heartland's 2.9% supply cost, Nasseh's service-mix-shift finding, the California 2026 Aspen injunctive terms, the Borsa systematic review). My first-person experience aligns with it. Where the data is thin, the post says so.